These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 9184715)
1. Possible toxic encephalopathy following high-dose intravenous haloperidol. Maxa JL; Taleghani AM; Ogu CC; Tanzi M Ann Pharmacother; 1997 Jun; 31(6):736-7. PubMed ID: 9184715 [TBL] [Abstract][Full Text] [Related]
2. Use of haloperidol infusions to control delirium in critically ill adults. Seneff MG; Mathews RA Ann Pharmacother; 1995; 29(7-8):690-3. PubMed ID: 8520081 [TBL] [Abstract][Full Text] [Related]
3. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196 [TBL] [Abstract][Full Text] [Related]
4. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation. MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013 [TBL] [Abstract][Full Text] [Related]
5. The use of haloperidol in the agitated, critically ill pediatric patient with burns. Brown RL; Henke A; Greenhalgh DG; Warden GD J Burn Care Rehabil; 1996; 17(1):34-8. PubMed ID: 8808357 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome during a change from haloperidol to risperidone. Reeves RR; Mack JE; Torres RA Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988 [TBL] [Abstract][Full Text] [Related]
7. High-dose neuroleptics and neuroleptic rotation for agitated delirium near the end of life. Bascom PB; Bordley JL; Lawton AJ Am J Hosp Palliat Care; 2014 Dec; 31(8):808-11. PubMed ID: 24081790 [TBL] [Abstract][Full Text] [Related]
8. Managing severe aggression in frontotemporal dementia. Powell A; Flynn P; Rischbieth S; McKellar D Australas Psychiatry; 2014 Feb; 22(1):86-9. PubMed ID: 24176944 [TBL] [Abstract][Full Text] [Related]
9. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder. Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985 [TBL] [Abstract][Full Text] [Related]
10. Haloperidol-induced torsade de pointes. O'Brien JM; Rockwood RP; Suh KI Ann Pharmacother; 1999 Oct; 33(10):1046-50. PubMed ID: 10534216 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial. Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684 [TBL] [Abstract][Full Text] [Related]
12. Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery. Perrault LP; Denault AY; Carrier M; Cartier R; Bélisle S Can J Anaesth; 2000 Mar; 47(3):251-4. PubMed ID: 10730737 [TBL] [Abstract][Full Text] [Related]
14. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. Tesar GE; Murray GB; Cassem NH J Clin Psychopharmacol; 1985 Dec; 5(6):344-7. PubMed ID: 4067002 [TBL] [Abstract][Full Text] [Related]
15. Hypotension associated with intravenous haloperidol and imipenem. Franco-Bronson K; Gajwani P J Clin Psychopharmacol; 1999 Oct; 19(5):480-1. PubMed ID: 10505596 [No Abstract] [Full Text] [Related]
16. [Sudden death following a single oral administration of haloperidol]. Remijnse PL; Eeckhout AM; van Guldener C Ned Tijdschr Geneeskd; 2002 Apr; 146(16):768-71. PubMed ID: 11998355 [TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome and cardiac surgery. A case report. Sirois F J Cardiovasc Surg (Torino); 2008 Oct; 49(5):695-6. PubMed ID: 18670390 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations. Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560 [TBL] [Abstract][Full Text] [Related]
19. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives. Silva RR; Muñoz DM; Daniel W; Barickman J; Friedhoff AJ J Clin Psychiatry; 1996 Mar; 57(3):129-35. PubMed ID: 8617698 [TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. Oosthuizen P; Emsley R; Jadri Turner H; Keyter N Int J Neuropsychopharmacol; 2004 Jun; 7(2):125-31. PubMed ID: 15003147 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]